D Larrey

Summary

Country: France

Publications

  1. ncbi Epidemiology and individual susceptibility to adverse drug reactions affecting the liver
    Dominique Larrey
    service d hépato gastroentérologie et transplantation, Hopital Saint Eloi, Montpellier, France
    Semin Liver Dis 22:145-55. 2002
  2. ncbi [From hepatic steatosis due to obesity to cirrhosis, in the absence of alcoholic intoxication]
    Dominique Larrey
    Service d hépatogastroentérologie et transplantation Hôpital Saint Eloi, 80 rue Augustin Fliche 34295 Montpellier
    Presse Med 32:512-8. 2003
  3. ncbi Drug-induced liver diseases
    D Larrey
    Service d Hépatogastro entérologie et Transplantation hépatique, Hopital Saint Eloi, Montpellier, France
    J Hepatol 32:77-88. 2000
  4. ncbi Drug-induced acute liver failure
    Dominique Larrey
    Department of Gastroenterology, Hepatology and Liver Transplantation, Hopital Saint Eloi, Montpellier School of Medicine and INSERM Unit 632, Montpellier, France
    Eur J Gastroenterol Hepatol 17:141-3. 2005
  5. ncbi [Bacterial hepatitis]
    Dominique Larrey
    , , CHU Montpellier, 80, rue Augustin Fliche, 34295 Montpellier Cedex 5
    Gastroenterol Clin Biol 27:B27-31. 2003
  6. ncbi [Non-alcoholic steatohepatitis: natural history and diagnosis]
    Dominique Larrey
    , , CHU Montpellier
    Gastroenterol Clin Biol 27:793-8. 2003
  7. ncbi [Chronic hepatitis C: apart from antiviral treatment what other measures should be recommended?]
    Dominique Larrey
    , , CHU Montpellier
    Gastroenterol Clin Biol 26:B283-90. 2002
  8. ncbi [Hepatotoxicity of immunosuppressants. Diagnostic approach]
    D Larrey
    , , 80, rue Augustin-Fliche, 34295 Montpellier Cedex 5, France
    Gastroenterol Clin Biol 32:S194-204. 2008
  9. ncbi Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients
    O Dereure
    Department of Dermatology Phlebology, CHRU Montpellier, Hopital Saint Eloi, 80 avenue Augustin Fliche, 34265 Montpellier cedex 5, France
    Br J Dermatol 147:1142-6. 2002
  10. ncbi Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?
    P Aguilar-Martinez
    Laboratory of Haematology, CHU of Montpellier, 34295 Montpellier, France
    Gut 48:836-42. 2001

Collaborators

Detail Information

Publications31

  1. ncbi Epidemiology and individual susceptibility to adverse drug reactions affecting the liver
    Dominique Larrey
    service d hépato gastroentérologie et transplantation, Hopital Saint Eloi, Montpellier, France
    Semin Liver Dis 22:145-55. 2002
    ....
  2. ncbi [From hepatic steatosis due to obesity to cirrhosis, in the absence of alcoholic intoxication]
    Dominique Larrey
    Service d hépatogastroentérologie et transplantation Hôpital Saint Eloi, 80 rue Augustin Fliche 34295 Montpellier
    Presse Med 32:512-8. 2003
    ....
  3. ncbi Drug-induced liver diseases
    D Larrey
    Service d Hépatogastro entérologie et Transplantation hépatique, Hopital Saint Eloi, Montpellier, France
    J Hepatol 32:77-88. 2000
    ..The prediction of the hepatotoxicity of new drugs must be improved. Investigations would be particularly useful for drugs having critical chemical structures and belonging to families with an established history of hepatotoxicity...
  4. ncbi Drug-induced acute liver failure
    Dominique Larrey
    Department of Gastroenterology, Hepatology and Liver Transplantation, Hopital Saint Eloi, Montpellier School of Medicine and INSERM Unit 632, Montpellier, France
    Eur J Gastroenterol Hepatol 17:141-3. 2005
    ..At the stage of liver failure, treatment is mostly supportive. Since irreversible damage is unpredictable, early transfer to a transplantation centre should be considered...
  5. ncbi [Bacterial hepatitis]
    Dominique Larrey
    , , CHU Montpellier, 80, rue Augustin Fliche, 34295 Montpellier Cedex 5
    Gastroenterol Clin Biol 27:B27-31. 2003
  6. ncbi [Non-alcoholic steatohepatitis: natural history and diagnosis]
    Dominique Larrey
    , , CHU Montpellier
    Gastroenterol Clin Biol 27:793-8. 2003
  7. ncbi [Chronic hepatitis C: apart from antiviral treatment what other measures should be recommended?]
    Dominique Larrey
    , , CHU Montpellier
    Gastroenterol Clin Biol 26:B283-90. 2002
  8. ncbi [Hepatotoxicity of immunosuppressants. Diagnostic approach]
    D Larrey
    , , 80, rue Augustin-Fliche, 34295 Montpellier Cedex 5, France
    Gastroenterol Clin Biol 32:S194-204. 2008
  9. ncbi Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients
    O Dereure
    Department of Dermatology Phlebology, CHRU Montpellier, Hopital Saint Eloi, 80 avenue Augustin Fliche, 34265 Montpellier cedex 5, France
    Br J Dermatol 147:1142-6. 2002
    ..By contrast, very few data are available with regard to distant skin reactions, particularly inflammatory lesions on other parts of the body...
  10. ncbi Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?
    P Aguilar-Martinez
    Laboratory of Haematology, CHU of Montpellier, 34295 Montpellier, France
    Gut 48:836-42. 2001
    ..But few H63D homozygotes with clinical manifestations of hereditary haemochromatosis (HH) have been reported. Concurrently, an increasing number of genes have been shown to interact with HFE in iron metabolism...
  11. ncbi Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation
    Georges Philippe Pageaux
    Liver Transplant Unit, Centre Hospitalier Universitaire CHU Saint Eloi, Montpellier, France
    Liver Transpl 12:1755-60. 2006
    ....
  12. ncbi [Is there a risk to prescribe paracetamol at therapeutic doses in patients with acute or chronic liver disease?]
    Dominique Larrey
    , , Montpellier
    Gastroenterol Clin Biol 30:753-5. 2006
  13. ncbi [Chronic hepatitis C: management of side effects of treatment]
    Dominique Larrey
    service d hépato gastroentérologie et transplantation, Hopital Saint Eloi, CHU Montpellier et INSERM U632, 80 rue Augustin Fliche, Montpellier Cedex 5
    Gastroenterol Clin Biol 31:4S20-8. 2007
    ..It is also essential to provide a well adapted therapeutic education to get an optimal compliance to the treatment and thereby a better chance of success...
  14. ncbi Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter?
    Georges Philippe Pageaux
    Fédération médico chirurgicale d Hépato gastroentérologie et Transplantation, Hopital Saint Eloi, 80 rue Augustin Fliche, 34295 CHU Montpellier Cedex 5, France
    J Hepatol 38:629-34. 2003
    ..The aim of this study was to distinguish the types of alcohol consumption after liver transplantation (LT) for alcoholic cirrhosis and to assess the consequences of heavy drinking...
  15. ncbi Is chronic hepatitis C virus infection a risk factor for breast cancer?
    Dominique Larrey
    Liver Unit and INSERM Unit 632, Saint Eloi Hospital, Montpellier University, 80 rue Augustin Fliche, Montpellier Cedex 5, France
    World J Gastroenterol 16:3687-91. 2010
    ..To evaluate the prevalence of breast tumors in adult females with chronic hepatitis C virus (HCV) infection...
  16. ncbi Hepatitis after intravenous injection of sublingual buprenorphine in acute hepatitis C carriers: report of two cases of disappearance of viral replication after acute hepatitis
    Helene Peyriere
    Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France
    Ann Pharmacother 43:973-7. 2009
    ..To report 2 cases of acute hepatitis related to intravenous administration of buprenorphine in hepatitis C-infected patients...
  17. ncbi The Southern French registry of genetic hemochromatosis: a tool for determining clinical prevalence of the disorder and genotype penetrance
    Patricia Aguilar-Martinez
    CHU of Montpellier Laboratory of Hematology, Hopital Saint Eloi, avenue Augustin Fliche, 34295 Montpellier Cedex 5, France
    Haematologica 95:551-6. 2010
    ..Despite great progress in understanding the mechanisms underlying genetic hemochromatosis, data on the prevalence and the penetrance of the disorder are conflicting...
  18. ncbi Are preoperative patterns of alcohol consumption predictive of relapse after liver transplantation for alcoholic liver disease?
    Pascal Perney
    , , Montpellier Cedex, France
    Transpl Int 18:1292-7. 2005
    ..05). Information on previous alcohol consumption (dependence, number of withdrawals, family history) helps to predict severe relapse after LT in patients with ALD, allowing early awareness and specific postoperative care...
  19. ncbi Cross hepatotoxicity between tricyclic antidepressants and phenothiazines
    A J Remy
    Department of Hepato Gastroenterology, Saint Eloi Hospital, Montpellier, France
    Eur J Gastroenterol Hepatol 7:373-6. 1995
    ..To describe a case of cross hepatotoxicity between tricyclic antidepressants and phenothiazines...
  20. ncbi Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis
    P Aguilar-Martinez
    Laboratory of Hematology, CHU de Montpellier, Montpellier, France
    Blood Cells Mol Dis 27:290-3. 2001
    ..Concurrently, none of the 18 hereditary hemochromatosis patients who had their TFR2 gene sequenced had any deleterious mutation. Thus, TFR2 mutations are not responsible for hemochromatosis in non-C282Y homozygous patients of our area...
  21. ncbi [Value of MRCP for diagnosis of biliary complications after liver transplantation]
    S Aufort
    Service d Imagerie Medicale, CHU Montpellier, Hopital Saint Eloi, 80, rue Augustin Fliche, 34295 Montpellier Cedex 5
    J Radiol 89:221-7. 2008
    ..To assess the value of MRCP in the detection of biliary complications after orthotopic liver transplantation...
  22. ncbi Use of human hepatocytes to investigate HCV infection
    Lydiane Pichard-Garcia
    INSERM U632, Hepatic Physiopathology, Montpellier, France
    Methods Mol Biol 640:447-62. 2010
    ..Adult primary human hepatocytes infected with natural serum-derived HCV virions represent the model that most closely mimics the physiological situation. This chapter describes our experience with this culture model...
  23. ncbi Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial
    Diego Garcia-Compean
    Service d Hepato Gastroenterologie, Hopital Saint Eloi, Montpellier, France
    Ann Hepatol 1:29-35. 2002
    ..05). Ascites recurrence rates and survival were similar in the two groups. In conclusion, Dextran-40 was thus not as efficacious as albumin for preventing PCD...
  24. ncbi Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance
    Eric Assenat
    Service de Chirurgie Digestive, Hopital Saint Eloi, Montpellier, France
    Hepatology 40:951-60. 2004
    ....
  25. ncbi Global sequencing approach for characterizing the molecular background of hereditary iron disorders
    Severine Cunat
    Laboratory of Haematology, CHU of Montpellier, Montpellier, France
    Clin Chem 53:2060-9. 2007
    ..This study aimed to develop a rapid automated method for sequencing the main genes involved...
  26. ncbi Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients
    Christophe Duvoux
    Liver Transplant Unit, AP HP Hopital Henri Mondor, 51 Avenue du Marechal de Lattre de Tassigny, 94010 Creteil, France
    Transplantation 74:1103-9. 2002
    ..The aim of this work was to identify specific risk factors for lymphoproliferative disorders after liver transplantation in adults...
  27. ncbi Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy
    Stefan Mauss
    Center for HIV and Hepatogastroenterology, , Germany
    AIDS 18:F21-5. 2004
    ..Treatment with antiretrovirals such as didanosine may increase the risk further...
  28. ncbi SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonresponders
    Christoph Sarrazin
    Department of Internal Medicine II, Saarland University Hospital, Homburg, Germany
    Gastroenterology 132:1270-8. 2007
    ....
  29. ncbi Hepatic findings in long-term clinical trials of ximelagatran
    William M Lee
    University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9151, USA
    Drug Saf 28:351-70. 2005
    ..In these studies, raised aminotransferase levels were observed during long-term use (>35 days). The aim of this analysis is to review the data regarding these hepatic findings in the long-term trials of ximelagatran...